• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by DocGo Inc. (Amendment)

    3/1/24 4:53:15 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care
    Get the next $DCGO alert in real time by email
    SC 13G/A 1 z31241sc13ga2.htm AMENDMENT NO. 2

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 2 )*

     

    DOCGO INC.
    (Name of Issuer)
     
    Common Stock
    (Title of Class of Securities)

     

      256086109  
      (CUSIP Number)  
     
    February 29, 2024
    (Date of Event Which Requires Filing of This Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      x Rule 13d-1(b)
         
      o Rule 13d-1(c)
         
      o Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

       
     

     

    CUSIP No.  256086109
    1

    NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Hood River Capital Management LLC 46-1294859

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     

     

    (a)x

    (b)o

    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH REPORTING

    PERSON WITH:

    5

    SOLE VOTING POWER

     

         

    6

    SHARED VOTING POWER

     

         

    7

    SOLE DISPOSITIVE POWER

     

    1,774,198

    8

    SHARED DISPOSITIVE POWER

     

         

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,774,198

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

     

    o

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    1.70%

    12

    TYPE OF REPORTING PERSON (see instructions)

     

    IA

     

       
     

     

    Item 1(a). Name of Issuer:
       
       DocGo, Inc.
       
    Item 1(b). Address of Issuer’s Principal Executive Offices:
       
       35 W. 35th Street, Floor 6   New York, NY  10001
       
    Item 2(a). Name of Person Filing:
       
       Hood River Capital Management LLC
       
    Item 2(b). Address of Principal Business Office or, if none, Residence:
         
       2373 PGA Blvd., Suite 200   Palm Beach Gardens, FL  33410
       
    Item 2(c). Citizenship:
       
       USA
       
    Item 2(d). Title of Class of Securities:
       
       COMMON
       
    Item 2(e). CUSIP Number:  256086109

     

       
     

     

    Item 3. If this Statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
      (a) o Broker or dealer registered under Section 15 of the Act;
      (b) o Bank as defined in Section 3(a)(6) of the Act;
      (c) o Insurance company as defined in Section 3(a)(19) of the Act;
      (d) o Investment company registered under Section 8 of the Investment Company Act of 1940;
      (e) x An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
      (f) o An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
      (g) o A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
      (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
      (j) o A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
      (k) o Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:      

     

    Item 4. Ownership.
      Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
       (a) Amount Beneficially Owned: 1,774,198   
       (b) Percent of Class: 1.70%   
       (c) Number of shares as to which such person has:
          (i) sole power to vote or to direct the vote: 0   
          (ii) shared power to vote or to direct the vote: 0   
          (iii) sole power to dispose or to direct the disposition of: 1,774,198   
          (iv) shared power to dispose or to direct the disposition of: 0   

     

       
     

     

    Item 5. Ownership of Five Percent or Less of a Class.
       
       If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
       
     Item 6. Ownership of More than Five Percent on Behalf of Another Person.
       
       Not applicable.
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
       
       Not applicable.
       
    Item 8. Identification and Classification of Members of the Group.
       
       Not applicable.
       
    Item 9. Notice of Dissolution of Group.
       
       Not applicable.
       
    Item 10. Certification.
       
       By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of and do not have the effect of changing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect for the time being.

     

       
     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

      March 1, 2024  
      Date  
         
      /s/ Robert Schmaltz  
      Signature  
         
      Robert Schmaltz, CCO  
      Name/Title  

     

     

     

     

     

    Get the next $DCGO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DCGO

    DatePrice TargetRatingAnalyst
    5/9/2025Buy → Neutral
    BTIG Research
    2/28/2025$5.00 → $2.85Buy → Hold
    Deutsche Bank
    8/18/2023$15.00Buy
    BTIG Research
    4/21/2023$11.00Overweight
    Cantor Fitzgerald
    4/19/2022$11.00Buy
    Deutsche Bank
    1/19/2022$14.00Buy
    Stifel
    12/21/2021$13.00Buy
    Canaccord Genuity
    12/7/2021$14.00Buy
    Needham
    More analyst ratings